The saponin QS-21, derived from Quillaja saponaria, has been clinically successful in vaccines due to its ability to elicit robust humoral and cellular immunity, exemplif...

This research addresses the critical need to improve vaccine adjuvants, which are essential for enhancing immune responses in subunit vaccines. While AS01 has demonstrate...

 Malaria remains a major global health challenge, particularly in endemic regions where effective vaccines are critically needed. Recent advances include the development ...

 This paper emphasizes the growing global burden of dementia, particularly Alzheimer's disease, which is predicted to nearly double by 2050 due to aging populatio...

 This study focuses on QS-21, a potent saponin adjuvant essential for human vaccines, traditionally sourced from the bark of mature Quillaja saponaria trees in Chile. The...

 The Quillaja saponaria tree, native to central Chile, has historically been valued for its soap-like bark containing saponins, which produce foam and have traditional cl...

The paper explores how various adjuvants influence the immune response and hematopoietic pathways, particularly focusing on megakaryocytes and platelets, which are emergi...

This paper addresses the critical global health challenge posed by dengue virus, emphasizing the complexities in developing a safe, effective, and long-lasting vaccine ca...